Delivery Order SPE2DB22D2108-SPE2DB24FU4PD

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $6.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,806.50, is for the delivery of TELMISARTAN-HCTZ 80-25 MG TAB UD 30S, which are pharmaceutical tablets. The contract is a firm fixed price delivery order with an ultimate completion date of April 9, 2025. The contract was awarded on April 8, 2025 and does not have a set-aside designation,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,984.40, is a Firm Fixed Price Delivery Order for the supply of TELMISARTAN-HCTZ 80-25 MG TAB UD 30S, a cardiovascular medication. The contract has an ultimate completion date of December 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a pharmaceutical product. The contract has a ceiling value of $20,286.87 and is a Delivery Order awarded under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a...
This federal contract award from the Defense Logistics Agency (DLA) was issued to the prime contractor Amerisourcebergen Drug Corp for the delivery of TELMISARTAN-HCTZ 80-25 MG TAB UD 30S, a pharmaceutical product. The contract has a total ceiling value of $5,362.48 and is structured as a firm fixed price delivery order with an ultimate completion date of January 8, 2025. The contract is not designated with any set-aside requirements. Amerisourcebergen Drug Corp is a major pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $4,185.78, is for the provision of TELMISARTAN-HCTZ 80-25 MG TAB UD 30S, a cardiovascular medication. The contract has an ultimate completion date of March 18, 2025 and is a Firm Fixed Price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TELMISARTAN-HCTZ 80-12.5 MG TB UD 30S medication. The contract has a ceiling value of $3,560.75 and a period of performance ending on March 12, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen Drug Corp is the prime contractor and holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of TELMISARTAN-HCTZ 80-25 MG TAB 30S, a pharmaceutical product. The contract has a ceiling value of $3,869.06 and is set to expire on July 19, 2024. AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award. The contract is a firm fixed-price delivery order and does not have a set-aside...
This is a Delivery Order contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TELMISARTAN-HCTZ 80-25 MG TAB 30S. The award has a ceiling value of $2,421.09 and a period of performance through July 19, 2024. The contract is a Firm Fixed Price arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S tablets. The contract has a firm fixed price and a ceiling value of $31,058.35, with a performance period ending on January 31, 2025. The contract is not associated with any set-aside requirements. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a $1,935.05 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the supply of 4564598993 - TELMISARTAN-HCTZ 80-25 MG TAB UD 30S, with an ultimate completion date of May 15, 2024. This delivery order is placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB24FU4PD
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of TELMISARTAN-HCTZ 80-25 MG TAB 30S, a pharmaceutical product. The contract has a ceiling value of $6,926.18 and a completion date of July 29, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and there is no mention of any subcontractors in the provided information. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 9:46 AM